Blog

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Photo from Pashtoon Kasi / X

Dec 20, 2023, 09:57

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Pashtoon Kasi, the Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X:

“Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal.

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient (pMMR/MSS) colorectal cancer.

Link: https://nature.com/articles/s41388-023-02835-y

GI24 will present full NEST-1 cohort.”

Source: Pashtoon Kasi / X

Balstilimab botensilimab botensilimab plus balstilimab cancer colorectal cancer Colorectal Cancer Research immunotherapy immunotherapy for colorectal cancer mismatch repair proficient Neoadjuvant botensilimab plus balstilimab OncoDaily Oncogene journal Oncology Pashtoon Kasi Weill Cornell Medicine

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage